• circHIF1A/miR-486-5p/GRHL2 Axis Drives LUAD Progression via

  2026-07-31

  This study delineates how circHIF1A orchestrates lung adenocarcinoma (LUAD) progression by sponging miR-486-5p, thereby upregulating GRHL2 and promoting macrophage M2 polarization. The findings reveal a pivotal ceRNA network shaping tumor microenvironment and identify the circHIF1A/miR-486-5p/GRHL2 axis as a promising biomarker and therapeutic target.

• Morning Exercise Accelerates Endurance Adaptation in Mice

  2026-07-31

  The reference study demonstrates that endurance training performed in the morning (early active phase) leads to more rapid and efficient performance adaptations in mice, compared to afternoon training. These findings highlight the critical influence of exercise timing on metabolic adaptation and inform both experimental design and translational research strategies.

• Calpeptin: Calpain Inhibitor Strategies for Fibrosis Researc

  2026-07-30

  Calpeptin offers nanomolar potency and proven selectivity as a calpain inhibitor, empowering advanced pulmonary fibrosis and cancer research. This guide translates recent breakthroughs and experimental know-how into actionable protocols, troubleshooting insights, and comparative advantages.

• Captopril as a Precision ACE Inhibitor for Translational Res

  2026-07-30

  Captopril enables targeted ACE inhibition for both hypertension and oncology research, facilitating reproducible results across cardiovascular and cancer cell models. This article delivers advanced workflow tips, contextual troubleshooting, and a translational bridge with actionable insights from bradykinin receptor modulation.

• Immobilized Microalgae Extracts Advance Antioxidant Packagin

  2026-07-29

  This study demonstrates a nearly twofold increase in biomass and a 170% boost in antioxidant polysaccharide yield by immobilizing Chlorella sp. in a silk fibroin–reinforced alginate matrix. The resulting extracts deliver strong, thermally stable antioxidant activity and significantly enhance the performance of biodegradable food packaging films.

• Honokiol as a Precision NF-κB Pathway Inhibitor in T-cell Me

  2026-07-29

  Honokiol, a potent small molecule from APExBIO, empowers researchers to dissect immunometabolic reprogramming and tumor microenvironment dynamics with unmatched selectivity. Its ability to block NF-κB activation and scavenge reactive oxygen species makes it a cornerstone for advanced inflammation and cancer research workflows.

• Bestatin Hydrochloride Modulates Angiotensin-Driven Neuronal

  2026-07-28

  This study demonstrates that Bestatin hydrochloride (Ubenimex), an aminopeptidase B inhibitor, significantly enhances angiotensin II and III-evoked neuronal responses in the rat brain, revealing a critical enzymatic step in neuropeptide activation. These findings have important implications for understanding neurovascular regulation and designing targeted experiments for neuropeptide and angiogenesis research.

• JHU-083: Redefining Glutaminase Inhibition in Neurological M

  2026-07-28

  Explore how JHU-083, a 6-diazo-5-oxo-L-norleucine precursor, enables advanced glutaminase pathway research and offers new insights for neurological disease modeling. This in-depth analysis reveals a critical bridge between redox biology and glutamate excitotoxicity.

• Acetylcholine Chloride: Deep Mechanistic Insights for CNS an

  2026-07-27

  Explore how Acetylcholine Chloride underpins advanced research into the acetylcholine neurotransmitter, with unique analysis of gut-brain cholinergic pathways and their translational implications for neuroscience and pediatric epilepsy.

• Technical Guidance for Angiotensin I/II (1-5) in RAS Researc

  2026-07-27

  Angiotensin I/II (1-5) provides a well-defined Asp-Arg-Val-Tyr-Ile peptide fragment for modeling blood pressure regulation and aldosterone release in renin-angiotensin system research. Its use is confined to cardiovascular and renal workflows due to specific solubility, storage, and mechanistic properties. It is not suitable for unrelated peptide studies or exploratory research outside the renin-angiotensin system.

• FPH1 (BRD-6125): Enabling Scalable Human Hepatocyte Expansio

  2026-07-26

  Explore how FPH1 (BRD-6125) empowers scalable, donor-independent human hepatocyte cultures and advances stem cell differentiation. This article offers an in-depth scientific analysis of FPH1’s mechanism, optimized protocols, and its unique role in the era of optogenetic gene regulation.

• Dexamethasone: Glucocorticoid Anti-inflammatory in Research

  2026-07-25

  Dexamethasone (DHAP) from APExBIO drives cutting-edge inflammation and neuroimmunology research with proven NF-κB inhibition and robust support for stem cell and autophagy workflows. This guide details practical protocols, troubleshooting, and experimental enhancements for reproducible results.

• PX-478 2HCl: Expanding HIF-1α Inhibition Beyond Oncology

  2026-07-24

  Explore how PX-478 2HCl, a potent HIF-1α inhibitor, is revolutionizing hypoxia research beyond traditional cancer models. Discover new translational insights for neurodevelopmental studies and advanced assay applications.

• Cy3-UTP: Illuminating RNA-Driven Organelle Dynamics in Viral

  2026-07-24

  Explore how Cy3-UTP empowers high-sensitivity RNA labeling for advanced studies in RNA-protein interactions and viral replication organelle dynamics. This article uniquely connects Cy3-modified uridine triphosphate to frontier applications in phase separation and coronavirus biology.

• PreScission Protease: Precision HRV 3C Cleavage in Tag Remov

  2026-07-23

  PreScission Protease (PSP) empowers researchers with precise, low-temperature fusion tag removal, safeguarding protein integrity for advanced molecular and chromatin studies. Its HRV 3C specificity streamlines workflows, making it a gold-standard tool for challenging protein purifications and nuclear condensate research.

15440 records 1/1030 page Next 12345 下5页 Last page